À propos de ce poste Senior Counsel, APAC Employment Law chez CSL
Your Opportunity
CSL (a top ASX company) is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia, immune deficiencies, iron deficiencies, kidney diseases and vaccines to prevent influenza.
A position is available as a Senior Counsel, APAC Employment Law. Working across the Asia Pacific region with a focus on Australia, while also supporting 8 other countries including China and Japan, you will be responsible for providing comprehensive advice on all aspects of employment and industrial relations law.
You will support and collaborate with partners across Human Resources (HR) (Business Partners, Employee Relations, Industrial Relations, Payroll, Talent, Compensation, Total Rewards and Global Mobility), Environmental Health and Safety, Enterprise Risk, Ethics & Compliance, and business professionals across the regional CSL business units.
Reporting to the Global Head, Labour & Employment Law you will
Provide succinct and direct employment law advice that is strategic, business-focussed, risk-conscious, compliant and actionable
Be a subject matter expert and provide direct legal guidance on all Australian employment law matters including employment disputes, restructures, investigations, terminations and compliance matters
Work with Industrial Relations to provide advice in relation to enterprise agreement strategy and negotiations, union consultation and collective disputes
Manage and assess employment law items across APAC, utilising local internal legal support where available
Oversee outside counsel, and represent company where appropriate, in litigation and agency matters
Your skills and experience
LLB or JD from an Australian university
Admission to practise in Victoria, Australia
Demonstrated experience in Australian Employment law matters, in-house experience desirable
Experience in conducting or overseeing complex employment related items and working effectively within a matrixed organisational structure
Apply now to join an Australia icon working at our new CBD global head office!
Closing Date for Applications: Friday 2nd October 2026
About CSL Behring
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
